SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial

NCT07682350 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

184

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant Recipient
Sodium Glucose Co-Transporter 2 Inhibitors
Non-Diabetic Patients
Randomized Controlled Trial (RCT)
Placebo Control Design
Post Transplant Diabetes Mellitus

Interventions

DRUG: SGLT2i
DRUG: Placebo

Sponsor

Odense University Hospital

Collaborators

[object Object]
[object Object]